Context Therapeutics

/Context Therapeutics

IPO

Context Therapeutics

Biopharmaceutical

Context Therapeutics® is a clinical-stage biopharmaceutical company dedicated to improving the lives of women living with cancer

Symbol

CNTX

Price Range
$12.00 - $14.00

Final Shares
1,500,000

Anticipated Date
August 6, 2021

Underwriters
FORDHAM FINANCIAL MANAGEMENT, INC.

This offering is no longer available

To view the prospectus for Context Therapeutics IPO, or any offering listed on ClickIPO,
download the ClickIPO app...

or a prospectus can be requested from G. Price at
ClickIPO Securities, LLC P. O. Box 21154, Mesa, AZ 85277

Secured By miniOrange